Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice

Leukemia

Volumn 29, Issue 4, 2015, Pages 927-938

  Shields, B J ^a,b   Alserihi, R ^a,b   Nasa, C ^a   Bogue, C ^c   Alexander, W S ^a,b   McCormack, M P ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPOIETICALLY EXPRESSED HOMEOBOX PROTEIN; HOMEODOMAIN PROTEIN; LIM PROTEIN; TRANSCRIPTION FACTOR LMO2; UNCLASSIFIED DRUG; CD4 ANTIGEN; CD8 ANTIGEN; HHEX PROTEIN, MOUSE; LMO2 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RESISTANCE; CELL RENEWAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; THYMOCYTE; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL; DEFICIENCY; DISEASE MODEL; GAMMA RADIATION; GENE DELETION; GENETICS; METABOLISM; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; THYMUS; TRANSGENIC MOUSE; TRANSPLANTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; DISEASE MODELS, ANIMAL; GAMMA RAYS; GENE DELETION; GENE EXPRESSION REGULATION, LEUKEMIC; HOMEODOMAIN PROTEINS; LIM DOMAIN PROTEINS; MICE; MICE, TRANSGENIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-KIT; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; THYMOCYTES; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 84927584759     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.292     Document Type: Article

References (43)

1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166-178.
2. Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: Where are we going and how do we get there? Blood 2012; 120: 1165-1174.
3. Pieters R, Carroll WL. Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am 2008; 55: 1-20, ix.
4. Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al. Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147-156.
5. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157-163.
6. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
7. Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005; 106: 274-286.
8. Homminga I, Pieters R, Langerak AW, De Rooi JJ, Stubbs A, Verstegen M et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 2011; 19: 484-497.
9. Inukai T, Kiyokawa N, Campana D, Coustan-Smith E, Kikuchi A, Kobayashi M et al. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: Results of the Tokyo Children's Cancer Study Group Study L99-15. Br J Haematol 2012; 156: 358-365.
10. Allen A, Sireci A, Colovai A, Pinkney K, Sulis M, Bhagat G et al. Early T-cell precursor leukemia/lymphoma in adults and children. Leuk Res 2013; 37: 1027-1034.
11. McCormack MP, Shields BJ, Jackson JT, Nasa C, Shi W, Slater NJ et al. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. Blood 2013; 122: 2093-2103.
12. Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH. The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci USA 1991; 88: 4367-4371.
13. Baer R. TAL1, TAL2 and LYL1: A family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. Semin Cancer Biol 1993; 4: 341-347.
14. Curtis DJ, McCormack MP. The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia. Clin Cancer Res 2010; 16: 5618-5623.
15. Matthews JM, Lester K, Joseph S, Curtis DJ. LIM-domain-only proteins in cancer. Nat Rev Cancer 2013; 13: 111-122.
16. Larson RC, Fisch P, Larson TA, Lavenir I, Langford T, King G et al. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene 1994; 9: 3675-3681.
17. McCormack MP, Young LF, Vasudevan S, De Graaf CA, Codrington R, Rabbitts TH et al. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 2010; 327: 879-883.
18. Hoang T. Of mice and men: How an oncogene transgresses the limits and predisposes to T cell acute lymphoblastic leukemia. Sci Transl Med 2010; 2: 21ps10.
19. Homminga I, Pieters R, Meijerink JP. NKL homeobox genes in leukemia. Leukemia 2012; 26: 572-581.
20. Crompton MR, Bartlett TJ, MacGregor AD, Manfioletti G, Buratti E, Giancotti V et al. Identification of a novel vertebrate homeobox gene expressed in haematopoietic cells. Nucleic Acids Res 1992; 20: 5661-5667.
21. Bedford FK, Ashworth A, Enver T, Wiedemann LM. HEX: A novel homeobox gene expressed during haematopoiesis and conserved between mouse and human. Nucleic Acids Res 1993; 21: 1245-1249.
22. George A, Morse HC 3rd, Justice MJ. The homeobox gene Hex induces T-cellderived lymphomas when overexpressed in hematopoietic precursor cells. Oncogene 2003; 22: 6764-6773.
23. Hunter MP, Wilson CM, Jiang X, Cong R, Vasavada H, Kaestner KH et al. The homeobox gene Hhex is essential for proper hepatoblast differentiation and bile duct morphogenesis. Dev Biol 2007; 308: 355-367.
24. Hallaq H, Pinter E, Enciso J, McGrath J, Zeiss C, Brueckner M et al. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels. Development 2004; 131: 5197-5209.
25. Nocka K, Tan JC, Chiu E, Chu TY, Ray P, Traktman P et al. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J 1990; 9: 1805-1813.
26. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995; 269: 1427-1429.
27. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001; 15: 763-774.
28. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001; 1: 4.
29. Seibler J, Zevnik B, Kuter-Luks B, Andreas S, Kern H, Hennek T et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res 2003; 31: E12.
30. Barbier V, Nowlan B, Levesque JP, Winkler IG. Flow cytometry analysis of cell cycling and proliferation in mouse hematopoietic stem and progenitor cells. Methods Mol Biol 2012; 844: 31-43.
31. Masuda K, Kakugawa K, Nakayama T, Minato N, Katsura Y, Kawamoto H. T cell lineage determination precedes the initiation of TCR beta gene rearrangement. J Immunol 2007; 179: 3699-3706.
32. Cleveland SM, Smith S, Tripathi R, Mathias EM, Goodings C, Elliott N et al. Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia. Stem Cells 2013; 31: 882-894.
33. Tremblay M, Tremblay CS, Herblot S, Aplan PD, Hebert J, Perreault C et al. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev 2010; 24: 1093-1105.
34. Tatarek J, Cullion K, Ashworth T, Gerstein R, Aster JC, Kelliher MA. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL. Blood 2011; 118: 1579-1590.
35. Rodewald HR, Kretzschmar K, Swat W, Takeda S. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 1995; 3: 313-319.
36. Kent D, Copley M, Benz C, Dykstra B, Bowie M, Eaves C. Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway. Clin Cancer Res 2008; 14: 1926-1930.
37. Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Blood 2008; 111: 5515-5523.
38. Smith S, Tripathi R, Goodings C, Cleveland S, Mathias E, Hardaway JA et al. LIM Domain Only-2 (LMO2) induces t-cell leukemia by two distinct pathways. PLoS ONE 2014; 9: E85883.
39. Martins VC, Busch K, Juraeva D, Blum C, Ludwig C, Rasche V et al. Cell competition is a tumour suppressor mechanism in the thymus. Nature 2014; 509: 465-470.
40. Treanor LM, Zhou S, Janke L, Churchman ML, Ma Z, Lu T et al. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential. J Exp Med 2014; 211: 701-713.
41. Treanor LM, Volanakis EJ, Zhou S, Lu T, Sherr CJ, Sorrentino BP. Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. Blood 2011; 117: 5453-5462.
42. Paietta E, Ferrando AA, Neuberg D, Bennett JM, Racevskis J, Lazarus H et al. Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. Blood 2004; 104: 558-560.
43. Lhermitte L, Ben Abdelali R, Villarese P, Bedjaoui N, Guillemot V, Trinquand A et al. Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL. Leukemia 2013; 27: 305-314.